Repurposing Colchicine for Heart Disease.

IF 11.2 1区 医学 Q1 PHARMACOLOGY & PHARMACY Annual review of pharmacology and toxicology Pub Date : 2022-01-06 Epub Date: 2021-09-30 DOI:10.1146/annurev-pharmtox-052120-020445
Nadia Bouabdallaoui, Jean-Claude Tardif
{"title":"Repurposing Colchicine for Heart Disease.","authors":"Nadia Bouabdallaoui,&nbsp;Jean-Claude Tardif","doi":"10.1146/annurev-pharmtox-052120-020445","DOIUrl":null,"url":null,"abstract":"<p><p>Colchicine is one of the most ancient medications still prescribed. It is extracted from the <i>Colchicum autumnale</i> plant and is routinely used because of its broad anti-inflammatory properties to treat gout and familial Mediterranean fever. Colchicine has shown efficacy in various clinical settings in which inflammation is a key component, and it has become first-line therapy for acute and recurrent pericarditis. Two landmark clinical trials have recently shown that colchicine significantly improves cardiovascular outcomes on background statin and antiplatelet therapy in patients with coronary artery disease, supporting its role for the prevention of atherothrombotic events. Favorable results have also emerged in atrial fibrillation. We herein briefly review the most recent data related to the multiple cardiovascular conditions for which colchicine has been successfully repurposed.</p>","PeriodicalId":8057,"journal":{"name":"Annual review of pharmacology and toxicology","volume":null,"pages":null},"PeriodicalIF":11.2000,"publicationDate":"2022-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annual review of pharmacology and toxicology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1146/annurev-pharmtox-052120-020445","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/9/30 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 3

Abstract

Colchicine is one of the most ancient medications still prescribed. It is extracted from the Colchicum autumnale plant and is routinely used because of its broad anti-inflammatory properties to treat gout and familial Mediterranean fever. Colchicine has shown efficacy in various clinical settings in which inflammation is a key component, and it has become first-line therapy for acute and recurrent pericarditis. Two landmark clinical trials have recently shown that colchicine significantly improves cardiovascular outcomes on background statin and antiplatelet therapy in patients with coronary artery disease, supporting its role for the prevention of atherothrombotic events. Favorable results have also emerged in atrial fibrillation. We herein briefly review the most recent data related to the multiple cardiovascular conditions for which colchicine has been successfully repurposed.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
秋水仙碱对心脏病的再利用
秋水仙碱是最古老的处方药之一。它是从秋水珠植物中提取的,由于其广泛的抗炎特性,通常用于治疗痛风和家族性地中海热。秋水仙碱在各种临床环境中显示出疗效,其中炎症是关键成分,它已成为急性和复发性心包炎的一线治疗方法。最近两项具有里程碑意义的临床试验表明,秋水仙碱可显著改善冠心病患者在他汀类药物和抗血小板治疗背景下的心血管结局,支持其在预防动脉粥样硬化血栓事件中的作用。在房颤方面也出现了良好的结果。我们在此简要回顾了最近有关秋水仙碱已成功重新应用于多种心血管疾病的最新数据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
27.80
自引率
0.00%
发文量
53
期刊介绍: Since 1961, the Annual Review of Pharmacology and Toxicology has been a comprehensive resource covering significant developments in pharmacology and toxicology. The journal encompasses various aspects, including receptors, transporters, enzymes, chemical agents, drug development science, and systems like the immune, nervous, gastrointestinal, cardiovascular, endocrine, and pulmonary systems. Special topics are also featured in this annual review.
期刊最新文献
Treating Sickle Cell Disease: Gene Therapy Approaches Weight Loss Blockbuster Development: A Role for Unimolecular Polypharmacology Gut Microbiota–Related Biomarkers in Immuno-Oncology Immunoregulation of Liver Fibrosis: New Opportunities for Antifibrotic Therapy Opportunities for Microphysiological Systems in Toxicity Testing of New Drug Modalities.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1